Aegon


The Life cycle

12/05/22 -"Aegon’s Q1 22 results were good on an operating basis however profitability was hit by non-operating items, namely fair value items, as a result of tumbling equity markets. The strong capital ..."

Pages
49
Language
English
Published on
12/05/22
You may also be interested by these reports :
11/11/26
Swiss Life released its 3Q26 results. While fee and commission income growth accelerated in Q3, this was driven by the first-time consolidation of ...

11/11/26
We have updated our forecasts following the publication of Hannover Re’s 3Q results. Hannover Re will present its outlook for 2027 and the medium ...

09/11/26
Hannover Re reported strong 3Q26 results, with net profit 9% above consensus. As with other reinsurers, however, attention is likely to stay on the ...

06/11/26
Swiss Re’s 3Q26 net income beat consensus by 17%, with each division ahead of expectations. However, New Business CSM remained weak in P&C, ...

EXECUTIVE SUMMARY

Updates Pension Risks
Target & Opinion Governance & Management
Business & Trends Graphics : Momentum
Money Making Graphics : MACD & Volumes
Debt Graphics : Sensitivities
Valuation Sector: Performance
DCF Sector: Key data
NAV/SOTP Sector: Ratios & Valorisation
Worth knowing Sector: Peers
Financials Sector: Analysis

CONFLICTS OF INTEREST

AlphaValue does not have nor seek any business with companies covered in AlphaValue Research paid by subscription. As a result, investors can be confident that there is no conflict of interest that could affect the objectivity of AlphaValue Research.

Corporate broking NO
Trading in corporate shares NO
Analyst ownership NO
Advising of corporate (strategy, marketing, debt, etc) NO
Research paid for by corporate NO
Provision of corporate access paid for by corporate NO
Link between and a banking entity NO
Brokerage activity at AlphaValue NO